journal article·2024-03Open access

A Methylazanediyl Bisacetamide Derivative Sensitizes Staphylococcus aureus Persisters to a Combination of Gentamicin And Daptomycin

Hee Young Heo, Guijin Zou, Seongeun Baek, Jae‐Seok Kim, Eleftherios Mylonakis, Frederick M. Ausubel, Huajian Gao, Wooseong Kim

Advanced Science· Volume 11· Issue 9

Abstract

Abstract Infections caused by Staphylococcus aureus, notably methicillin‐resistant S. aureus (MRSA), pose treatment challenges due to its ability to tolerate antibiotics and develop antibiotic resistance. The former, a mechanism independent of genetic changes, allows bacteria to withstand antibiotics by altering metabolic processes. Here, a potent methylazanediyl bisacetamide derivative, MB6, is described, which selectively targets MRSA membranes over mammalian membranes without observable resistance development. Although MB6 is effective against growing MRSA cells, its antimicrobial activity against MRSA persisters is limited. Nevertheless, MB6 significantly potentiates the bactericidal activity of gentamicin against MRSA persisters by facilitating gentamicin uptake. In addition, MB6 in combination with daptomycin exhibits enhanced anti‐persister activity through mutual reinforcement of their membrane‐disrupting activities. Crucially, the “triple” combination of MB6, gentamicin, and daptomycin exhibits a marked enhancement in the killing of MRSA persisters compared to individual components or any double combinations. These findings underscore the potential of MB6 to function as a potent and selective membrane‐active antimicrobial adjuvant to enhance the efficacy of existing antibiotics against persister cells. The molecular mechanisms of MB6 elucidated in this study provide valuable insights for designing anti‐persister adjuvants and for developing new antimicrobial combination strategies to overcome the current limitations of antibiotic treatments.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Antimicrobial Resistance in Staphylococcus · Bacterial biofilms and quorum sensing · Antimicrobial Peptides and Activities

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Pharmacy Graduate School of Pharmaceutical Sciences Ewha Womans University Seoul 03760 Republic of Korea

Institute of High Performance Computing (IHPC) Agency for Science Technology and Research (A*STAR) Singapore 138632 Republic of Singapore

Department of Laboratory Medicine Kangdong Sacred Heart Hospital Hallym University College of Medicine Seoul 05355 Republic of Korea

Department of Medicine Houston Methodist Hospital Houston TX 77030 USA

Department of Molecular Biology Massachusetts General Hospital Boston MA 02114 USA

Department of Genetics Harvard Medical School Boston MA 02115 USA

School of Mechanical and Aerospace Engineering College of Engineering Nanyang Technological University Singapore 639789 Republic of Singapore

Funding

National Research Foundation of Korea · National Institute of Allergy and Infectious Diseases · Korea Basic Science Institute · Ministry of Education - Singapore

References (69)

Show source-provided references
1. 10.1038/nrmicro.2016.3410.1038/nrmicro.2016.34 ↗
2. 10.1146/annurev-micro-020518-11565010.1146/annurev-micro-020518-115650 ↗
3. 10.15252/embr.20205103410.15252/embr.202051034 ↗
4. 10.1038/s41579-019-0196-310.1038/s41579-019-0196-3 ↗
5. 10.1038/s41579-020-0378-z10.1038/s41579-020-0378-z ↗
6. 10.1038/s41579-022-00682-410.1038/s41579-022-00682-4 ↗
7. 10.1038/nmicrobiol.2016.5110.1038/nmicrobiol.2016.51 ↗
8. 10.1016/j.chembiol.2019.07.00910.1016/j.chembiol.2019.07.009 ↗
9. 10.1128/mr.51.3.341-350.198710.1128/mr.51.3.341-350.1987 ↗
10. 10.1038/nature1006910.1038/nature10069 ↗
11. 10.1186/1471-2180-6-5310.1186/1471-2180-6-53 ↗
12. 10.1073/pnas.071171210510.1073/pnas.0711712105 ↗
13. 10.1128/mbio.00480-2210.1128/mbio.00480-22 ↗
14. 10.1038/nature2615710.1038/nature26157 ↗
15. 10.1073/pnas.190470011610.1073/pnas.1904700116 ↗
16. Miller W. R. · Cold Spring Harb Perspect Med · 2016 · 6
17. 10.1159/00034244910.1159/000342449 ↗
18. 10.1371/journal.pone.015090710.1371/journal.pone.0150907 ↗
19. Barros E. M. · Antimicrob. Agents Chemother. · 2019 · 63
20. 10.1038/s41467-022-29717-310.1038/s41467-022-29717-3 ↗
21. 10.1128/AAC.00799-1310.1128/AAC.00799-13 ↗
22. Lutgring J. D. · J Clin Microbiol · 2018 · 56
23. 10.1128/mBio.00112-1210.1128/mBio.00112-12 ↗
24. 10.1038/nrd397510.1038/nrd3975 ↗
25. 10.3389/fcimb.2021.68451510.3389/fcimb.2021.684515 ↗
26. 10.1073/pnas.060405510310.1073/pnas.0604055103 ↗
27. 10.1128/JCM.01121-1410.1128/JCM.01121-14 ↗
28. 10.1128/AAC.00039-0610.1128/AAC.00039-06 ↗
29. 10.1128/aem.63.6.2421-2431.199710.1128/aem.63.6.2421-2431.1997 ↗
30. 10.1038/nrmicro247410.1038/nrmicro2474 ↗
31. 10.1016/j.biopha.2022.11297710.1016/j.biopha.2022.112977 ↗
32. 10.1002/advs.20210074910.1002/advs.202100749 ↗
33. 10.1371/journal.ppat.100990910.1371/journal.ppat.1009909 ↗
34. 10.1073/pnas.130701011010.1073/pnas.1307010110 ↗
35. 10.1021/ct100494z10.1021/ct100494z ↗
36. 10.1016/j.chemphyslip.2017.06.00710.1016/j.chemphyslip.2017.06.007 ↗
37. 10.1016/j.bbamem.2012.05.02710.1016/j.bbamem.2012.05.027 ↗
38. 10.1007/s00228-015-1832-010.1007/s00228-015-1832-0 ↗
39. Kim W. · mBio · 2020 · 11
40. 10.1021/acsinfecdis.8b0016110.1021/acsinfecdis.8b00161 ↗
41. 10.1371/journal.pone.012764010.1371/journal.pone.0127640 ↗
42. 10.1021/la501226v10.1021/la501226v ↗
43. 10.1016/j.bmc.2016.05.05210.1016/j.bmc.2016.05.052 ↗
44. 10.1021/acsinfecdis.1c0031610.1021/acsinfecdis.1c00316 ↗
45. 10.1074/jbc.M114.55444410.1074/jbc.M114.554444 ↗
46. 10.1073/pnas.181206611610.1073/pnas.1812066116 ↗
47. 10.1021/acsinfecdis.2c0008710.1021/acsinfecdis.2c00087 ↗
48. 10.1128/MMBR.65.2.232-260.200110.1128/MMBR.65.2.232-260.2001 ↗
49. 10.1128/AAC.49.7.2735-2745.200510.1128/AAC.49.7.2735-2745.2005 ↗
50. 10.1093/jac/dkx34910.1093/jac/dkx349 ↗
51. 10.3390/antibiotics909053810.3390/antibiotics9090538 ↗
52. 10.1128/AAC.00290-0610.1128/AAC.00290-06 ↗
53. 10.1128/AAC.00051-0910.1128/AAC.00051-09 ↗
54. 10.1128/CMR.00134-1410.1128/CMR.00134-14 ↗
55. 10.1016/j.jacc.2016.10.06610.1016/j.jacc.2016.10.066 ↗
56. 10.1021/jp207013v10.1021/jp207013v ↗
57. 10.1016/j.eml.2020.10081710.1016/j.eml.2020.100817 ↗
58. Clinical and Laboratory Standards Institute · 2012
59. 10.1021/ct700301q10.1021/ct700301q ↗
60. 10.1007/s00249-011-0700-910.1007/s00249-011-0700-9 ↗
61. 10.1021/acs.jctc.8b0076810.1021/acs.jctc.8b00768 ↗
62. 10.1021/ct200196m10.1021/ct200196m ↗
63. 10.1016/S0006-3495(97)78845-310.1016/S0006-3495(97)78845-3 ↗
64. 10.1039/c4sc00034j10.1039/c4sc00034j ↗
65. 10.1021/j100308a03810.1021/j100308a038 ↗
66. 10.1063/1.47011710.1063/1.470117 ↗
67. 10.1016/S0959-440X(00)00194-910.1016/S0959-440X(00)00194-9 ↗
68. 10.1002/jcc.54013081210.1002/jcc.540130812 ↗
69. Cui K. · Microbiol Spectr · 2023 · 11